OTC Pharmaceuticals - Russia

  • Russia
  • Revenue in the OTC Pharmaceuticals market amounts to €5.08bn in 2024. The market is expected to grow annually by 3.21% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of €1.53bn in 2024.
  • In global comparison, most revenue is generated in the United States (€37,700m in 2024).
  • In relation to total population figures, per person revenues of €35.29 are generated in 2024.
  • In the OTC Pharmaceuticals market, 12.3% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Marché
 
Région
 
Comparaison de régions
 
Monnaie
 

Analyst Opinion

The OTC Pharmaceuticals market in Russia is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trajectory.

Customer preferences play a crucial role in the development of the OTC Pharmaceuticals market in Russia. Consumers are increasingly seeking convenience and accessibility when it comes to healthcare products. They prefer over-the-counter medications that can be easily purchased without a prescription, allowing them to self-diagnose and self-medicate common ailments.

This preference for self-care and empowerment is driving the demand for OTC Pharmaceuticals in Russia. Trends in the market further support the growth of the OTC Pharmaceuticals sector in Russia. One notable trend is the increasing prevalence of lifestyle-related health issues, such as stress, insomnia, and digestive problems.

As a result, there is a growing demand for OTC medications that address these specific health concerns. Additionally, the aging population in Russia is driving the demand for OTC products that cater to the needs of older individuals, such as joint pain relief and vitamins for overall health and wellness. Local special circumstances also contribute to the development of the OTC Pharmaceuticals market in Russia.

The country has a vast territory with a diverse population, ranging from urban to rural areas. This geographical diversity creates different healthcare needs and accessibility challenges. In rural areas, for example, access to healthcare facilities and professional medical advice may be limited.

As a result, consumers in these areas rely heavily on OTC medications for self-treatment. Furthermore, the high cost of prescription medications in Russia encourages consumers to opt for OTC alternatives, which are often more affordable. Underlying macroeconomic factors also play a significant role in the growth of the OTC Pharmaceuticals market in Russia.

The country's improving economic conditions and rising disposable incomes have led to increased healthcare spending. As consumers have more financial resources at their disposal, they are more willing to invest in OTC medications for their healthcare needs. Additionally, the government's focus on promoting self-care and reducing the burden on the healthcare system has created a favorable environment for the OTC Pharmaceuticals market to thrive.

In conclusion, the OTC Pharmaceuticals market in Russia is experiencing robust growth and development. Customer preferences for convenience and accessibility, along with trends in the market, local special circumstances, and underlying macroeconomic factors, are driving this positive trajectory. As the market continues to evolve, it is expected to offer even more diverse and innovative OTC products to cater to the evolving healthcare needs of Russian consumers.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Vue d’ensemble

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Veuillez patienter

Contact

Des questions ? Nous nous ferons un plaisir de vous aider.
Statista Locations
Contact Temitope Ifekoya
Temitope Ifekoya
Customer Relations

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (États-Unis)

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asie)

Lun - Ven, 9:00 - 17:00 h (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asie)

Lun - Ven, 10:00 - 18:00 h (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Lun - Ven, 9:00 - 18:00 h (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Amérique latine)

Lun - Ven, 9:00 - 18:00 h (EST)